Company
CEO Message
Corporate Profile
Management
History
Access
Business ＆ Technology
Technology
Application to small molecule cancer drugs
Application to nucleic acid therapeutics
Application to cosmetics
Business Model
Gene therapy
Regenerative Medicine – Acti-PRP
Pipeline
Investor Relations
News Releases
Financial Highlights
IR Report
Stock Information
Stock Price
Analyst Coverage
JP
/ EN
NanoCarrier Co.,Ltd.
>
Investor Relations
>
IR Report
Investor Relations
IR Report
FY 2020（April 1, 2019 ～ March 31, 2020）
IR Report
E-book
FY 2019（April 1, 2018 ～ March 31, 2019）
IR Report
E-book
FY 2018（April 1, 2017 ～ March 31, 2018）
IR Report
E-book
FY 2017（April 1, 2016 ～ March 31, 2017）
IR Report
E-book
FY 2016（April 1, 2015 ～ March 31, 2016）
IR Report
E-book
FY 2015（April 1, 2014 ～ March 31, 2015）
IR Report
E-book
FY 2014（April 1, 2013 ～ March 31, 2014）
IR Report
E-book
